Puma Biotechnology
Financial ratios & Valuation

Forward Multiples (2025 – 2028)

2025202620272028
Price/Earnings ratio
20.5315.59-33.26-19.96
Price/Sales ratio
0.900.880.991.02
Earnings per Share (EPS)
$0.24$0.32$-0.15$-0.25

Historical Multiples (2014 – 2023)

2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 TTM Median
Valuation Ratios
Price/Earnings ratio
-40.00-10.52-3.70-12.58-6.79-4.10-6.76-4.24207.209.4565.00K-6.79
Price/Sales ratio
N/AN/AN/A132.643.071.241.800.480.820.860.571.24
Price/Book Value ratio
48.5412.224.8768.9322.5019.38-67.67-51.478.743.816.0119.38
Price/Cash Flow ratio
-73.57-16.30-7.21-21.29-32.0315.14507.565.96-11.967.55-8.21-32.03
Price/Free Cash Flow ratio
-72.36-16.17-6.86-16.48-31.2415.35-21.095.96-8.2814.20-5.69-31.24
Price/Earnings Growth ratio
-0.26-0.18-0.322.420.100.140.230.08-2.010.000.130.10
Dividend Yield
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Profitability Indicator Ratios
Gross Profit Margin
N/AN/AN/A79.78%86.21%86.48%82.49%74.84%75.83%73.39%75.83%86.48%
Operating Profit Margin
N/AN/AN/A-1055.59%-37.72%-14.35%-13.50%-3.51%10.39%13.85%13.47%-37.72%
Pretax Profit Margin
N/AN/AN/A-1054.15%-45.25%-27.76%-26.56%-11.37%0.21%9.62%0.20%-45.25%
Net Profit Margin
N/AN/AN/A-1054.15%-45.25%-30.37%-26.65%-11.49%0.4%9.16%0.00%-45.25%
Effective Tax Rate
0.66%0.73%0.77%0.75%6.97%-9.42%-0.33%-1.04%100%4.77%99.56%6.97%
Return on Assets
-87.24%-99.77%-109.18%-176.40%-43.84%-35.21%-24.56%-12.84%0.41%9.36%0.00%-43.84%
Return On Equity
-121.36%-116.16%-131.55%-547.84%-331.13%-472.70%1000%1212.5%4.22%40.40%0.01%-331.13%
Return on Capital Employed
-120.27%-115.86%-128.45%-272.79%-49.32%-27.13%-23.39%-7.60%16.39%24.88%21.24%-49.32%
Liquidity Ratios
Current Ratio
3.366.896.311.823.021.831.27N/AN/AN/A1.731.83
Quick Ratio
1.046.896.311.782.981.791.241.211.671.501.591.79
Cash ratio
0.860.975.191.401.610.660.740.570.980.850.980.98
Days of Sales Outstanding
N/AN/AN/A127.4231.9138.7341.4146.8864.5975.1067.6531.91
Days of Inventory outstanding
N/AN/AN/A132.2427.6931.4431.9940.7329.9841.2229.9827.69
Operating Cycle
N/AN/AN/A259.6659.6070.1773.4187.6294.57116.3346.6670.17
Days of Payables Outstanding
N/A8.37K6.36K1.80K218.19190.26111.8764.0242.6640.1142.66190.26
Cash Conversion Cycle
N/AN/AN/A-1.54K-158.59-120.09-38.4523.5951.9176.2232.38-158.59
Debt Ratios
Debt Ratio
N/AN/AN/A0.290.580.410.410.440.440.450.900.58
Debt Equity Ratio
N/AN/AN/A0.904.425.57-16.90-41.944.551.959.274.42
Long-term Debt to Capitalization
N/AN/AN/A0.470.810.841.071.020.810.550.830.81
Total Debt to Capitalization
N/AN/AN/A0.470.810.841.061.020.810.660.840.81
Interest Coverage Ratio
N/AN/AN/A-406.09-8.61-2.52-2.16N/AN/AN/A2.65-8.61
Cash Flow to Debt Ratio
N/AN/AN/A-3.55-0.150.220.000.20-0.160.25-0.13-0.15
Company Equity Multiplier
1.391.161.203.107.5513.42-40.70-94.4110.284.3110.277.55
Cash Flow Ratios
Operating Cash Flow / Sales Ratio
N/AN/AN/A-6.22-0.090.080.000.08-0.060.11-0.06-0.09
Free Cash Flow / Operating Cash Flow Ratio
1.011.001.051.291.020.98-24.0511.440.531.441.02
Cash Flow Coverage Ratio
N/AN/AN/A-3.55-0.150.220.000.20-0.160.25-0.13-0.15
Short Term Coverage Ratio
N/AN/AN/AN/AN/A8.530.045.79N/A0.69-3.828.53
Dividend Payout Ratio
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A